Cargando…

Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis

BACKGROUND: Recent trials suggested that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose co-transporter-2 (SGLT-2) inhibitors reduced cardiovascular events. Comparative effectiveness of these new antidiabetic drug classes remains unclear. We therefore performed a network met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fei, Yue, Tsoi, Man-Fung, Cheung, Bernard Man Yung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714383/ https://www.ncbi.nlm.nih.gov/pubmed/31462224 http://dx.doi.org/10.1186/s12933-019-0916-z

Ejemplares similares

Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes
por: Lo, Chris Wai Hang, et al.
Publicado: (2021)

Cardiovascular Benefits of New Antidiabetic Drug Classes: A Network Meta-analysis
por: Cheung, BMY, et al.
Publicado: (2020)

Duration of dual antiplatelet therapy after drug-eluting stent implantation: Meta-analysis of large randomised controlled trials
por: Tsoi, Man-Fung, et al.
Publicado: (2015)

Association between the liver fat score (LFS) and cardiovascular diseases in the national health and nutrition examination survey 1999–2016
por: Lee, Chun-On, et al.
Publicado: (2021)

Effects of antidiabetic drugs on left ventricular function/dysfunction: a systematic review and network meta-analysis
por: Zhang, Da-Peng, et al.
Publicado: (2020)

A 2020 Vision of Hypertension
por: Cheung, Bernard M.Y., et al.
Publicado: (2020)

Cardiovascular outcomes and safety with antidiabetic drugs
por: Aldossari, Khaled K.
Publicado: (2018)

Blood lead level and risk of hypertension in the United States National Health and Nutrition Examination Survey 1999–2016
por: Tsoi, Man Fung, et al.
Publicado: (2021)

Epidemiology of gout in Hong Kong: a population-based study from 2006 to 2016
por: Tsoi, Man Fung, et al.
Publicado: (2020)

Effects of oral antidiabetic drugs on left ventricular mass in patients with type 2 diabetes mellitus: a network meta-analysis
por: Ida, Satoshi, et al.
Publicado: (2018)

Recent cardiovascular outcome trials of antidiabetic drugs: A comparative analysis
por: Singh, Awadhesh Kumar, et al.
Publicado: (2017)

Efficacy and safety of newer P2Y(12) inhibitors for acute coronary syndrome: a network meta-analysis
por: Fei, Yue, et al.
Publicado: (2020)

Use of ticagrelor and the risks of pneumonia and pneumonia-specific death in patients with non-acute coronary syndrome conditions: a population-based cohort study
por: Feng, Qi, et al.
Publicado: (2021)

Pharmacogenetics of new classes of antidiabetic drugs
por: Kadrić, Selma Imamović, et al.
Publicado: (2021)

Meta‐analysed numbers needed to treat of novel antidiabetic drugs for cardiovascular outcomes
por: Wolff, Georg, et al.
Publicado: (2022)

Cardiovascular mortality and oral antidiabetic drugs: protocol for a systematic review and network meta-analysis
por: Goyat, Rashmi, et al.
Publicado: (2017)

Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes
por: Stapff, Manfred Paul
Publicado: (2018)

Comparison of Cardiovascular Events Among Users of Different Classes of Antihypertension Medications: A Systematic Review and Network Meta-analysis
por: Wei, Jingkai, et al.
Publicado: (2020)

Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis
por: D’Andrea, Elvira, et al.
Publicado: (2020)

Association between use of oral-antidiabetic drugs and the risk of aortic aneurysm: a nested case–control analysis
por: Hsu, Chien-Yi, et al.
Publicado: (2016)

Repurposing Antidiabetic Drugs for Cardiovascular Disease
por: Schubert, Mario, et al.
Publicado: (2020)

Heart failure hospitalization risk associated with use of two classes of oral antidiabetic medications: an observational, real-world analysis
por: Gautam, Santosh, et al.
Publicado: (2017)

Comparative effectiveness of oral antidiabetic drugs in preventing cardiovascular mortality and morbidity: A network meta-analysis
por: Lee, Gyeongsil, et al.
Publicado: (2017)

Antidiabetic treatment patterns and specialty care utilization among patients with type 2 diabetes and cardiovascular disease
por: Pantalone, Kevin M., et al.
Publicado: (2018)

Comparative efficacy of novel antidiabetic drugs on cardiovascular and renal outcomes in patients with diabetic kidney disease: A systematic review and network meta‐analysis
por: Cao, Hongwei, et al.
Publicado: (2022)

Re‐adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study‐level meta‐analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase‐4 (DPP‐4) inhibitors
por: Scirica, Benjamin M., et al.
Publicado: (2022)

Posters from the 24th Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy: Best Poster Award – First Prize: Network Meta-analysis to Determine the Optimal Level of Systolic Blood Pressure for Hypertensive Patients
por: Cheung, BMY, et al.
Publicado: (2020)

Effects of the Multidisciplinary Risk Assessment and Management Program for Patients with Diabetes Mellitus (RAMP-DM) on biomedical outcomes, observed cardiovascular events and cardiovascular risks in primary care: a longitudinal comparative study
por: Jiao, Fang Fang, et al.
Publicado: (2014)

Absolute treatment effects for the primary outcome and all-cause mortality in the cardiovascular outcome trials of new antidiabetic drugs: a meta-analysis of digitalized individual patient data
por: Kuss, Oliver, et al.
Publicado: (2022)

Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomes
por: Fisman, Enrique Z., et al.
Publicado: (2015)

Prevalence of Childhood Obesity in the United States 1999 - 2018: A 20-Year Analysis
por: Li, Hang Long, et al.
Publicado: (2021)

Prevalence of Childhood Obesity in the United States in 1999–2018: A 20-Year Analysis
por: Tsoi, Man-Fung, et al.
Publicado: (2022)

Growth differentiation factor-15 is associated with cardiovascular outcomes in patients with coronary artery disease
por: Li, Man, et al.
Publicado: (2020)

Selective Insulin Receptor Modulators (SIRM): A New Class of Antidiabetes Drugs?
por: Vigneri, Riccardo, et al.
Publicado: (2012)

Effects of sodium‐glucose cotransporter type 2 inhibitors on cardiovascular, renal, and safety outcomes in patients with cardiovascular disease: a meta‐analysis of randomized controlled trials
por: Zheng, Caiyun, et al.
Publicado: (2021)

Beyond Blood Sugar: Investigating the Cardiovascular Effects of Antidiabetic Drugs
por: Ahmad, Binish A, et al.
Publicado: (2023)

Incidence and Lethality of Suicidal Overdoses by Drug Class
por: Miller, Ted R., et al.
Publicado: (2020)

Vancomycin-associated acute kidney injury in Hong Kong in 2012–2016
por: Qin, Xuzhen, et al.
Publicado: (2020)

Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis
por: McGuire, Darren K., et al.
Publicado: (2020)

Meta-analysis of the impact of alpha-glucosidase inhibitors on incident diabetes and cardiovascular outcomes
por: Coleman, Ruth L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ccggbkqihk819rjqone3vebc4o